AI in Population Health: Exploring Sub-Fields and Applications

By Sumona Bose

February 1, 2024

Introduction

Artificial intelligence (AI) has influenced various aspects of healthcare, from genetics research to clinical care. However, its adoption in population health settings has been slower. In this article, we aim to shed light on different sub-fields of AI and their potential applications in population health, emphasizing the need for decision-makers to understand AI concepts. By exploring these sub-fields, we can harness the power of AI to make more informed decisions and improve public health outcomes. This article will explore the sub fields of AI in population and public health.

Understanding AI Concepts

AI methods offer the ability to analyze vast amounts of complex and diverse data, providing valuable insights and contributing to sense making. This capacity makes AI particularly appealing for health applications, including personalized medicine. However, the term “AI” encompasses various approaches and fields, leading to confusion. To bridge this knowledge gap, we will outline different AI sub-fields and their relevance to population health.

Exploring AI Sub-Fields

Machine Learning

Machine learning, a widely used sub-field of AI, has found success in clinical problem-solving. However, its application in population health and public health has been limited. Machine learning and traditional statistical approaches have the potential to leverage big data to understand and predict healthcare and population health outcomes. However, caution must be exercised to avoid biased data and unequal access to technology, which can perpetuate health inequities.

Population Health & Responsible AI
Figure 1: Population Health and Responsible AI

Natural Language Processing (NLP)

NLP focuses on understanding and processing human language. In population health, NLP can be used to analyze large volumes of text data, such as electronic health records and social media posts, to identify patterns and trends. This can aid in disease surveillance, early detection, and monitoring of public health concerns.

Computer Vision

Computer vision involves the interpretation of visual data, such as medical images and videos. In population health, computer vision can assist in the analysis of imaging data for disease diagnosis and monitoring. It can also be used for surveillance purposes, such as monitoring social distancing compliance during pandemics.

Predictive Analytics

Predictive analytics utilizes historical data to make predictions about future events. In population health, predictive analytics can help identify individuals at risk of certain diseases or adverse health outcomes. This information can guide targeted interventions and resource allocation to prevent or mitigate health issues.

Conclusion

The field of AI holds immense potential for improving population health outcomes. While AI has already made significant advancements in genetics research and clinical care, its application in population health settings has been slower. By understanding the various sub-fields of AI and their relevance to population health, decision-makers can harness the power of AI to make more informed decisions and address public health challenges. Exploring sub fields of AI in population health makes for a necessary discourse to positively intervene in population health.

Reference url

Recent Posts

Transforming Healthcare with the Gene Therapy Access Model

By HEOR Staff Writer

October 1, 2025

The gene therapy access model is a groundbreaking federal-state collaborative framework designed to improve how transformative treatments are distributed and financed, particularly within Medicaid. This innovative approach answers a key question for patients and policymakers: How can we ensur...
Pfizer Trump Drug Prices: A Landmark Deal for Affordable Medications
Summary President Trump announced that Pfizer has agreed to lower drug prices. This is part of a broader initiative to reduce prescription drug costs in the United States, particularly f...
PhRMA’s Patient Access Investment: $500 Billion Commitment to Domestic Infrastructure and Care

By HEOR Staff Writer

September 30, 2025

Yesterday PhRMA announced steps to boosting patient access to treatments. The announcement showcases the U.S. biopharmaceutical industry’s initiative to enhance patient access and stimulate economic growth. The announcement outlines a remarkable $500 billion in new U.S. infrastructure spending. I...